Although the current study increased our understanding of the association between P2RY13 expression and ccRCC, it still has certain limitations: First, many clinical aspects, such as details of the patients’ treatment, should be considered to completely understand the precise role of P2RY13 in the development of ccRCC. The gene discussed is P2RY13; the disease is nonpapillary renal cell carcinoma.